November 4, 2026 · Clinical radiology · DOI: 10.1016/j.crad.2026.107499

Ultrasound-guided microwave ablation for biopsy-proven breast fibroadenomas ≤3 cm: clinical, imaging, and safety outcomes at 12-month follow-up.

Listen to this summary

This retrospective study of 27 biopsy-proven breast fibroadenomas (≤3.0 cm) asks whether ultrasound-guided microwave ablation (MWA) can safely shrink these benign tumours as a minimally invasive alternative to surgical excision. Over 12 months, mean maximum diameter fell by about 73% (20.7 to 5.6 mm) and mean volume fell by about 73.5%, with 16 of 27 lesions achieving over 90% volume reduction and no major adverse events or burns reported. The authors conclude that MWA is a promising, well-tolerated option for appropriately selected symptomatic patients, though the small, uncontrolled, retrospective design limits generalizability.

M Yağtu, G Sezgin

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play